QQ客服 官方微博 反馈留言

	The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations
	Shi, Puyu; Zhang, Shuo; Zhu, Lei; Qian, Guoging; Ren, Hui; Ramalingam, Suresh S.; Chen, Mingwei; Sun, Shi-Yong
刊名	TRANSLATIONAL ONCOLOGY
	2019
卷号	12页码:705-713
ISSN号	1936-5233
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2827495
专题	西安交通大学
推荐引用方式 GB/T 7714	Shi, Puyu,Zhang, Shuo,Zhu, Lei,et al. The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations[J]. TRANSLATIONAL ONCOLOGY,2019,12:705-713.
APA	Shi, Puyu.,Zhang, Shuo.,Zhu, Lei.,Qian, Guoging.,Ren, Hui.,...&Sun, Shi-Yong.(2019).The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations.TRANSLATIONAL ONCOLOGY,12,705-713.
MLA	Shi, Puyu,et al."The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAI-Induced Apoptosis in NSCL Cells with Activating EGFR Mutations".TRANSLATIONAL ONCOLOGY 12(2019):705-713.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。